Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for December 2016. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
BodyFIX Without Wrap Works for Radiotherapy Immobilization
FRIDAY, Dec. 30, 2016 (HealthDay News) — The BodyFIX without wrap is suitable for clinical immobilization during radiotherapy, according to a study published online Dec. 20 in the Journal of Medical Radiation Sciences.
Full Text (subscription or payment may be required)
No Effect for BUP TAP Catheter on Chronic Pain After Breast Recon
FRIDAY, Dec. 30, 2016 (HealthDay News) — For patients undergoing autologous breast reconstruction, the incidence of chronic postsurgical pain (CPSP) does not differ for patients receiving transversus abdominis plane (TAP) catheters delivering bupivacaine or saline bolus, according to a study published online Dec. 20 in Pain Practice.
Full Text (subscription or payment may be required)
Uric Acid May Mark Progression for Nasopharyngeal Cancer
FRIDAY, Dec. 30, 2016 (HealthDay News) — There is a direct correlation between the pretreatment serum uric acid (SUA) level and tumor progression in patients with locally advanced nasopharyngeal carcinoma (NPC), according to a study published online Dec. 20 in Head & Neck.
Full Text (subscription or payment may be required)
Panel of 88 SNPs Predicts Breast CA Risk in Women at High Risk
FRIDAY, Dec. 30, 2016 (HealthDay News) — A panel of 88 single nucleotide polymorphisms (SNPs) can predict breast cancer risk, according to a study published online Dec. 28 in the Journal of Clinical Oncology.
Incidence of Melanoma Continues to Rise in Majority of States
THURSDAY, Dec. 29, 2016 (HealthDay News) — There is regional variation in the incidence and death rates for melanoma; and sex, sexual orientation, and race/ethnicity impact the prevalence of indoor tanning use, according to two research letters published online Dec. 28 in JAMA Dermatology.
Full Text – Mounessa
Full Text – Blashill (subscription or payment may be required)
Iron Deficiency Anemia Ups Risk of Hearing Loss in U.S. Adults
THURSDAY, Dec. 29, 2016 (HealthDay News) — Among U.S. adults, hearing loss is associated with iron deficiency anemia (IDA), according to a study published online Dec. 29 in JAMA Otolaryngology-Head & Neck Surgery.
Case Report: Adoptive T-Cell Tx Shows Promise in Glioblastoma
THURSDAY, Dec. 29, 2016 (HealthDay News) — Treatment with autologous chimeric antigen receptor (CAR)-engineered T cells targeting the tumor-associated antigen interleukin-13 receptor alpha 2 (IL13Rα2) is associated with tumor regression in recurrent multifocal glioblastoma, according to a case report published in the Dec. 29 issue of the New England Journal of Medicine.
Full Text (subscription or payment may be required)
Selumetinib Active in Children With Neurofibromatosis Type 1
THURSDAY, Dec. 29, 2016 (HealthDay News) — The oral selective inhibitor of MAPK kinase 1 and 2, selumetinib, is active in children with neurofibromatosis type 1 and inoperable plexiform neurofibromas, according to a study published in the Dec. 29 issue of the New England Journal of Medicine.
Full Text (subscription or payment may be required)
Reoperation Risk for Nonpalpable Breast Lesions Higher for DCIS
THURSDAY, Dec. 29, 2016 (HealthDay News) — For women undergoing wire-guided breast conserving surgery (BCS) for nonpalpable breast lesions, the risk of reoperation is higher for those with ductal carcinoma in situ (DCIS) than those with invasive breast cancer (IBC), according to a study published online Dec. 21 in JAMA Surgery.
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Triple-Negative Breast CA Risk Up for Blacks With Benign Breast Dz
THURSDAY, Dec. 29, 2016 (HealthDay News) — African-American (AA) identity is associated with increased risk of triple-negative breast cancer (TNBC) among women with a prior diagnosis of benign breast disease (BBD), according to a study published online Dec. 22 in JAMA Oncology.
Full Text (subscription or payment may be required)
Optimal Timing ID’d for Flu Shot During Three-Week Chemo Cycle
WEDNESDAY, Dec. 28, 2016 (HealthDay News) — For adults with solid cancer undergoing three-week cytotoxic chemotherapy cycles, antibody responses are comparable for influenza vaccination on day one and 11, according to a study published online Dec. 20 in Cancer.
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Personal Health Care Spending Continues to Soar in the U.S.
TUESDAY, Dec. 27, 2016 (HealthDay News) — From 1996 to 2013 there were considerable increases in personal health care spending in the United States, with the highest amounts for diabetes, ischemic heart disease, and low back and neck pain, according to a study published in the Dec. 27 issue of the Journal of the American Medical Association.
Full Text
Editorial (subscription or payment may be required)
Confocal Microscopy Aids Surgical Removal of Tumors From Eyelid
TUESDAY, Dec. 27, 2016 (HealthDay News) — Imaging using fluorescence confocal microscopy (FCM) analysis in the reflectance mode and with an “en face” scanning can control tumor margins of eyelid basal cell carcinoma (BCC) to optimize surgical management, according to a study published online Dec. 19 in Clinical & Experimental Ophthalmology.
Full Text (subscription or payment may be required)
Less Intense Surveillance OK for Some Prostate Cancer Cases
FRIDAY, Dec. 23, 2016 (HealthDay News) — Certain patients on active surveillance for prostate cancer may be eligible for less intensive surveillance, according to a study published in the January issue of The Journal of Urology.
Early Surgery Ups Mortality Risk for Some Endometrial CA Patients
FRIDAY, Dec. 23, 2016 (HealthDay News) — For patients diagnosed with endometrial cancer, surgery within the first two weeks of diagnosis is associated with increased risk of mortality, according to a study published online Dec. 8 in the American Journal of Obstetrics & Gynecology.
Full Text (subscription or payment may be required)
ASCO Updates Guideline for SNB in Early-Stage Breast Cancer
THURSDAY, Dec. 22, 2016 (HealthDay News) — Recommendations for use of sentinel node biopsy (SNB) in early-stage breast cancer are unchanged from 2014, according to a clinical practice guideline update published online Dec. 12 in the Journal of Clinical Oncology.
Single-Dose LMWH Can Interfere With Algorithm for DVT Diagnosis
THURSDAY, Dec. 22, 2016 (HealthDay News) — A single dose of low-molecular-weight heparin (LMWH) given the previous day can reduce D-dimer and potentially risk non-identification of a deep vein thrombosis (DVT), according to a research letter published online Dec. 15 in the International Journal of Laboratory Hematology.
Full Text (subscription or payment may be required)
Surgeon Input on Contralateral Prophylactic Mastectomy Needed
WEDNESDAY, Dec. 21, 2016 (HealthDay News) — Many patients with newly diagnosed unilateral breast cancer consider contralateral prophylactic mastectomy (CPM), according to a study published online Dec. 21 in JAMA Surgery.
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Melanoma Incidence, Mortality Continue to Rise in the U.S.
WEDNESDAY, Dec. 21, 2016 (HealthDay News) — The burden of melanoma is increasing in the United States, according to a research letter published online Dec. 21 in JAMA Dermatology.
Radiation Dose to Head & Neck Tied to Thyroid Dysfunction Risk
WEDNESDAY, Dec. 21, 2016 (HealthDay News) — For patients with head and neck cancer receiving radiotherapy (RT), thyroid dysfunction is a dose-related complication, with increased risk for female sex and concurrent chemotherapy, according to a study published online Dec. 1 in Head & Neck.
Full Text (subscription or payment may be required)
Regular Aspirin Use Linked to Reduced Risk of Pancreatic CA
TUESDAY, Dec. 20, 2016 (HealthDay News) — Regular aspirin use is associated with reduced risk of pancreatic cancer in a Chinese cohort, according to a study published online Dec. 20 in Cancer Epidemiology, Biomarkers & Prevention.
Full Text (subscription or payment may be required)
MicroRNAs 203 and 205 Are Prognostic in Cutaneous SCC
TUESDAY, Dec. 20, 2016 (HealthDay News) — MicroRNAs (miR-203 and miR-205) could be useful prognostic markers in cutaneous squamous cell carcinoma, with distinct expression and associations, according to a study published online Dec. 11 in the British Journal of Dermatology.
Full Text (subscription or payment may be required)
Pathologists Vary in Suggested Therapy for Melanocytic Lesions
TUESDAY, Dec. 20, 2016 (HealthDay News) — Pathologists have wide variability in treatment suggestions for melanocytic lesions, according to a study published in the January issue of the Journal of the American Academy of Dermatology.
Full Text (subscription or payment may be required)
Health Care Provider Burnout Negatively Affects Quality, Safety
TUESDAY, Dec. 20, 2016 (HealthDay News) — Health care provider burnout is negatively associated with quality and safety of health care, according to a meta-analysis published recently in the Journal of General Internal Medicine.
Full Text (subscription or payment may be required)
FDA Grants Fast-Track Approval to Ovarian Cancer Drug
MONDAY, Dec. 19, 2016 (HealthDay News) — The drug Rubraca (rucaparib) has been granted accelerated approval by the U.S. Food and Drug Administration to treat advanced ovarian cancer.
No Link for Transfused Red Blood Cell Storage, Mortality
MONDAY, Dec. 19, 2016 (HealthDay News) — For patients who received transfusions in Sweden and Denmark from 2003 to 2012, there was no correlation between the length of red blood cell (RBC) storage and mortality, according to a study published online Dec. 20 in the Annals of Internal Medicine.
Full Text (subscription or payment may be required)
DEA Announces Critical Changes in Registration Renewal Process
MONDAY, Dec. 19, 2016 (HealthDay News) — The Drug Enforcement Administration (DEA) has announced critical changes in its registration renewal process, according to a report published by the American Academy of Family Physicians.
Diabetes Ups Risk of HCC, Death in Patients With Hepatitis C
MONDAY, Dec. 19, 2016 (HealthDay News) — For hepatitis C virus (HCV)-infected patients, diabetes mellitus (DM) is associated with increased risk of hepatocellular carcinoma (HCC) development and all-cause mortality, according to a study published online Dec. 8 in the Journal of Gastroenterology and Hepatology.
Full Text (subscription or payment may be required)
Adjuvant Chemo Plus CRT Best in Nasopharyngeal Carcinoma
MONDAY, Dec. 19, 2016 (HealthDay News) — For nonmetastatic nasopharyngeal carcinoma, the addition of adjuvant chemotherapy (AC) to chemoradiotherapy (CRT) is associated with the highest survival benefit, according to research published online Dec. 5 in the Journal of Clinical Oncology.
BRCA1/2, ATM Mutations ID Risk for Lethal Prostate Cancer
FRIDAY, Dec. 16, 2016 (HealthDay News) — The rate of germline BRCA1/2 and ATM mutations is significantly higher among patients with lethal prostate cancer (PCa) and is an independent predictor of lethal PCa, according to a study published online Dec. 15 in European Urology.
Full Text (subscription or payment may be required)
Imiquimod Has Sustained Benefit for Basal Cell Carcinoma
FRIDAY, Dec. 16, 2016 (HealthDay News) — For superficial or nodular basal cell carcinoma at low-risk sites, imiquimod has lower treatment success rates than surgery but the benefit is sustained at five years, according to a study published online Dec. 5 in the Journal of Investigative Dermatology.
Full Text (subscription or payment may be required)
CRC in Patients Under 50 Often Caused by Genetic Mutations
FRIDAY, Dec. 16, 2016 (HealthDay News) — As many as one in six colorectal cancer patients under the age of 50 have genetic traits that greatly increase the risk of cancer, according to a study published online Dec. 15 in JAMA Oncology.
Full Text
Editorial (subscription or payment may be required)
MRI Has a Role to Play After Negative Prostate Biopsy
THURSDAY, Dec. 15, 2016 (HealthDay News) — Magnetic resonance imaging (MRI) and MRI-targeted biopsies have a role in the diagnosis and treatment of patients with a prior negative prostate biopsy, according to a review published in the December issue of The Journal of Urology.
Microsurgical Head and Neck Reconstruction Is Cost-Effective
THURSDAY, Dec. 15, 2016 (HealthDay News) — For patients with squamous cell carcinoma (SCC), microsurgical head and neck reconstruction is cost-effective compared with locoregional flaps, according to a study published online Nov. 29 in Head & Neck.
Full Text (subscription or payment may be required)
ASS1 Loss Identified in Invasive Bladder Cancer
THURSDAY, Dec. 15, 2016 (HealthDay News) — Loss of argininosuccinate synthetase 1 (ASS1), a key enzyme for arginine synthesis, occurs in invasive bladder cancer, according to a study published online Dec. 12 in The American Journal of Pathology.
Full Text (subscription or payment may be required)
SIOP Scale Best for Detecting Ototoxicity With Cisplatin Tx
THURSDAY, Dec. 15, 2016 (HealthDay News) — The Society for Industrial and Organizational Psychology Ototoxicity Scale (SIOP) seems to be best for classifying ototoxicity in cisplatin-treated pediatric patients, according to a study published online Dec. 12 in the Journal of Clinical Oncology.
Full Text (subscription or payment may be required)
Triple-Negative Breast Cancer Subtype Chemosensitive
WEDNESDAY, Dec. 14, 2016 (HealthDay News) — For patients with triple-negative breast cancer (TNBC), a BRCA-deficiency (BRCA-D) subtype is chemosensitive, according to a study published online Dec. 13 in PLOS Medicine.
Type of Treatment Impacts Recurrence in Laryngeal SCC
WEDNESDAY, Dec. 14, 2016 (HealthDay News) — For patients with laryngeal squamous cell carcinoma (SCC), factors predictive of recurrence include neck metastasis at presentation and nonsurgical treatment, according to a study published online Nov. 30 in Head & Neck.
Full Text (subscription or payment may be required)
Cetuximab + Chemoradiation Can Cure HIV-Associated Anal Cancer
WEDNESDAY, Dec. 14, 2016 (HealthDay News) — Definitive chemoradiation (CRT) can potentially cure HIV-associated squamous cell carcinoma of the anal canal (SCCAC), with the addition of cetuximab resulting in less locoregional failure (LRF), according to a study published online Dec. 12 in the Journal of Clinical Oncology.
Full Text (subscription or payment may be required)
Outcomes-Based Pricing Suggested for New, Costly Drugs
WEDNESDAY, Dec. 14, 2016 (HealthDay News) — Outcomes-based pricing for novel and expensive biopharmaceuticals is supported in an Ideas and Opinions piece published online Dec. 13 in the Annals of Internal Medicine.
Full Text (subscription or payment may be required)
Atezolizumab Effective in Late-Stage Non-Small-Cell Lung Cancer
TUESDAY, Dec. 13, 2016 (HealthDay News) — The immunotherapy atezolizumab extends the survival of previously treated non-small-cell lung cancer patients for several months and causes fewer side effects than docetaxel, according to a study published online Dec. 12 in The Lancet.
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
OSA Is Risk Factor for Recurrent Pulmonary Embolism
TUESDAY, Dec. 13, 2016 (HealthDay News) — For patients who stop oral anticoagulation (OAC) for a first episode of pulmonary embolism (PE), obstructive sleep apnea (OSA) is a risk factor for PE recurrence and restarting OAC for a new thromboembolic event, according to a study published in the December issue of CHEST.
Full Text (subscription or payment may be required)
Methylation of PITX2 DNA Feasible in Prostate Biopsies
TUESDAY, Dec. 13, 2016 (HealthDay News) — For patients with prostate cancer (PCa), methylation of the paired-like homeodomain transcription factor 2 (PITX2) gene is feasible for individualized risk assessment in prostate core biopsies before surgery, according to a study published online Dec. 8 in the Journal of Molecular Diagnostics.
Full Text (subscription or payment may be required)
Social Isolation Can Adversely Affect Breast Cancer Survival
MONDAY, Dec. 12, 2016 (HealthDay News) — Social isolation may impede long-term breast cancer survival, according to a study published online Dec. 12 in Cancer.
Full Text (subscription or payment may be required)
Drones Deemed Safe for Blood Transportation
MONDAY, Dec. 12, 2016 (HealthDay News) — Blood products don’t seem to suffer damage when transported by drones, according to a study published online Nov. 11 in Transfusion.
Full Text (subscription or payment may be required)
Stepped Care Likely to Be Cost-Effective in Head & Neck, Lung CA
MONDAY, Dec. 12, 2016 (HealthDay News) — A stepped care (SC) program is likely to be cost-effective for patients with head and neck cancer or lung cancer who have psychological distress, according to a study published online Dec. 5 in the Journal of Clinical Oncology.
Cytotoxic T-Cells Can Induce Metastatic CRC Regression
FRIDAY, Dec. 9, 2016 (HealthDay News) — Administration of cytotoxic T-cells targeting mutant KRAS G12D can induce tumor regression in metastatic colorectal cancer, according to a case report published in the Dec. 8 issue of the New England Journal of Medicine.
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Screening Cuts Transfusion-Transmitted Babesiosis Risk
FRIDAY, Dec. 9, 2016 (HealthDay News) — Screening for Babesia microti antibodies and DNA in blood-donation samples is associated with a reduction in the risk of transfusion-transmitted babesiosis, according to a study published in the Dec. 8 issue of the New England Journal of Medicine.
Full Text (subscription or payment may be required)
Personalized Vaccine Effective Against Acute Myeloid Leukemia
THURSDAY, Dec. 8, 2016 (HealthDay News) — A vaccine made from patient-derived acute myeloid leukemia cells and dendritic cells can dramatically increase the chance of long-term survival against acute myeloid leukemia, according to research published in the Dec. 7 issue of Science Translational Medicine.
Full Text (subscription or payment may be required)
Prevalence of Disability 2.7 Percent at U.S. Medical Schools
WEDNESDAY, Dec. 7, 2016 (HealthDay News) — The prevalence of disability is 2.7 percent among medical students at U.S. allopathic medical schools, according to a research letter published in the Dec. 6 issue of the Journal of the American Medical Association, a theme issue of medical education.
Full Text (subscription or payment may be required)
Learning Interventions Can Improve Med Student Well-Being
WEDNESDAY, Dec. 7, 2016 (HealthDay News) — Specific learning interventions may improve emotional well-being among medical students, according to a review published in the Dec. 6 issue of the Journal of the American Medical Association, a theme issue on medical education.
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Number of Cancer Cases, Deaths Up Globally
WEDNESDAY, Dec. 7, 2016 (HealthDay News) — Cancer cases rose 33 percent worldwide in the past 10 years, according to a report published online Dec. 3 in JAMA Oncology.
Depression, Suicide Ideation Prevalent in Medical Students
TUESDAY, Dec. 6, 2016 (HealthDay News) — The prevalences of depression or depressive symptoms and suicide ideation are 27.2 and 11.1 percent, respectively, among medical students, according to a review published in the Dec. 6 issue of the Journal of the American Medical Association, a theme issue on medical education.
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
HPV16 DNA From Fine-Needle Aspirations OK for Diagnosis
TUESDAY, Dec. 6, 2016 (HealthDay News) — HPV16 DNA detected in fine-needle aspirations from neck masses is a reliable indicator for diagnosis of an HPV-positive oropharyngeal squamous cell carcinoma (SCC), according to a study published Nov. 29 in Head & Neck.
Full Text (subscription or payment may be required)
Biosimilar Promising for ERBB2+ Breast Cancer Treatment
MONDAY, Dec. 5, 2016 (HealthDay News) — A proposed biosimilar is comparable to trastuzumab for women with ERBB2-positive metastatic breast cancer, according to a study published online Dec. 1 in the Journal of the American Medical Association.
Full Text
Editorial 1
Editorial 2
Multimodal Breast Cancer Tx May Up Cytokines, Comorbidities
MONDAY, Dec. 5, 2016 (HealthDay News) — Breast cancer survivors who undergo multimodal treatment have higher cytokines and comorbidities than controls without cancer, according to a study published online Nov. 28 in the Journal of Clinical Oncology.
Review: Methodological Limitations for OSCC Biomarkers
MONDAY, Dec. 5, 2016 (HealthDay News) — Methodological concerns have limited the analysis of saliva-based biomarkers for oral squamous cell carcinoma (OSCC), according to a review published online Nov. 29 in Head and Neck.
Full Text (subscription or payment may be required)
Acute, Noncardiac Mortality Risk Up for CA Patients With STEMI
FRIDAY, Dec. 2, 2016 (HealthDay News) — Cancer survivors with ST-segment elevation myocardial infarction (STEMI) have increased acute in-hospital and long-term noncardiac mortality risk but no increased acute or long-term cardiac mortality risk with guideline-recommended cardiac care, according to a study published in the December issue of the Mayo Clinic Proceedings.
Full Text (subscription or payment may be required)
Alcohol Intake Linked to Increase in Risk of Melanoma
FRIDAY, Dec. 2, 2016 (HealthDay News) — Alcohol intake is associated with increased risk of melanoma, especially in relatively ultraviolet (UV)-spared areas, according to a study published in the December issue of Cancer, Epidemiology, Biomarkers & Prevention.
Full Text (subscription or payment may be required)
Meds Don’t Cut Trastuzumab-Tied Left Ventricular Remodeling
FRIDAY, Dec. 2, 2016 (HealthDay News) — For patients with human epidermal growth factor receptor 2-overexpressing (HER2-positive) early breast cancer, perindopril and bisoprolol do not prevent trastuzumab-mediated left ventricular remodeling, according to a study published online Nov. 28 in the Journal of Clinical Oncology.
Psilocybin Can Pull Cancer Patients Quickly Out of Despair
THURSDAY, Dec. 1, 2016 (HealthDay News) — A single dose of psilocybin can quickly lifts the spirits of cancer patients, and the effect can last as long as six months, according to two studies published online Dec. 1 in the Journal of Psychopharmacology.
Full Text – Griffiths
Full Text – Ross
Editorial
AND: Vegetarian Diet a Healthy, Environmentally Sound Choice
THURSDAY, Dec. 1, 2016 (HealthDay News) — Vegetarian diets are healthy for people of all ages, as well as the environment, according to a new position statement from the Academy of Nutrition and Dietetics (AND). The report has been published in the December issue of the Journal of the Academy of Nutrition and Dietetics.
Increased VTE Risk for Men Starting Testosterone Therapy
THURSDAY, Dec. 1, 2016 (HealthDay News) — Starting testosterone treatment is associated with an increased risk of venous thromboembolism (VTE), peaking within six months and declining thereafter, according to a study published online Nov. 30 in The BMJ.
CDC: Fewer U.S. Families Struggling to Pay Medical Bills
THURSDAY, Dec. 1, 2016 (HealthDay News) — The number of people in families having problems paying medical bills fell by nearly 13 million from 2011 through the first six months of 2016, according to a report published by the U.S. Centers for Disease Control and Prevention’s National Center for Health Statistics (NCHS).
Study Supports Smoking Cessation for Smokers of Any Age
THURSDAY, Dec. 1, 2016 (HealthDay News) — Age at smoking initiation and cessation continue to be important predictors of mortality in U.S. adults over age 70, according to a study published online Nov. 29 in the American Journal of Preventive Medicine.
Copyright © 2017 ScoutNews, LLC. All rights reserved.
